IMI to hold fourth quarter 2003 update webcast & conference call TORONTO, March 4 /PRNewswire-FirstCall/ -- IMI International Medical Innovations Inc. (TSX: IMI, Amex: IME) today announced it will hold a conference call and webcast on Tuesday, March9, 2004 at 10:30 a.m. (ET) to provide a corporate strategic update for the fourth quarter of fiscal 2003 and to preview year-end results. The event will be hosted by Dr. Brent Norton, President and CEO; Ron Hosking, Vice President and CFO; and Sarah Borg-Olivier, Director, Communications. Please dial in five minutes prior to start time: Date: Tuesday, March 9, 2004 Time: 10:30 a.m. ET Webcast: http://www.imimedical.com/ or http://www.newswire.ca/ Conference Call Numbers: (416) 640-4127 (Toronto) (800) 814-4857 (North America) A webcast will be accessible for three months at http://www.imimedical.com/. A replay of the call willbe available until March 16, 2004 by dialing (416) 640-1917 (Toronto) or (877) 289-8525 (North America) and entering access code 21041345 followed by the number sign. IMI is a world leader in predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection and monitoring of life-threatening diseases, particularly cardiovascular disease and cancer. IMI's lead product is a non-invasive skin test for coronary artery disease. IMI's cancer products in development include ColorectAlert(TM), a screening test for colorectal cancer, LungAlert(TM), a screening test for lung cancer, and a new test for breast cancer. For further information, please visit the company's website at http://www.imimedical.com/. DATASOURCE: IMI International Medical Innovations Inc. CONTACT: please contact Sarah Borg-Olivier, Director, Communications, (416) 222-3449 ext. 27,

Copyright